Synthaverse (WAR:SVE) Valuation Rank


WAR:SVE Synthaverse SA WAR:SVE
55 GF Score
Price zł2.81
GF Value zł3.03
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Synthaverse Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Synthaverse Valuation Rank Related Terms

WAR:SVE
55GF Score
Synthaverse SA WAR:SVE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Synthaverse (WAR:SVE) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of zł2.81 is trading 7.3% below its estimated GF Value™ of zł3.03. GuruFocus considers Synthaverse to be Fairly Valued.

Key valuation signals for WAR:SVE:

  • Valuation Rank:
  • GF Value™: zł3.03 vs. price of zł2.81 (7.3% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:SVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synthaverse Business Description

Other Exchanges 6NQ:Germany
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
55GF Score

Get the complete analysis for WAR:SVE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.81
Price
zł3.03
GF Value